Company Profile - Surface Oncology Inc

Introduction

Surface Oncology Inc (Surface Oncology) is an immuno-oncology company. It develops novel antibody therapies for the treatment of cancer. The company’s product portfolio includes SRF388, to treat various diseases like renal cell carcinoma, hepatocellular carcinoma, and non-small-cell lung cancer; SRF617, to treat various tumors like gastric cancer, prostate cancer, PD-(L)1 relapsed cancer, and pancreatic cancer. Surface Oncology also provides SRF114, NZV930 and GSK4381562 antibodies. It also carries out research and development activities and pre-clinical studies. The company has entered two strategic collaborations to advance our next-generation cancer therapies partners which include Novartis and GSK. Surface Oncology is headquartered in Cambridge, Massachusetts, the US.